{
  "meta": {
    "title": "Osteoporosis",
    "url": "https://brainandscalpel.vercel.app/osteoporosis-56736381.html",
    "scrapedAt": "2025-11-29T18:33:53.635Z"
  },
  "questions": [
    {
      "id": 3955,
      "choices": [
        {
          "id": 15799,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neutral protamine Hagedorn</span></span></span></p>"
        },
        {
          "id": 15800,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin glulisine</span></span></span></p>"
        },
        {
          "id": 15801,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin glargine</span></span></span></p>"
        },
        {
          "id": 15802,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lente insulin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Longest acting insulin among the following is?</span></span></span></p>",
      "unique_key": "Q8610995",
      "question_audio": null,
      "question_video": null,
      "map_id": 36152,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Insulin glargine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin glargine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the<strong> longest-acting insulin </strong>among the options listed. It is a <strong>long-acting basal insulin </strong>analog with a <strong>duration of action</strong> that can <strong>last up to 24 hours,</strong> providing a<strong> steady level of insulin </strong>that mimics the <strong>natural basal secretion</strong> by the <strong>pancreas.</strong> <strong>Insulin glargine</strong> is designed to <strong>help control blood sugar levels throughout the day and night, </strong>making it particularly useful for managing<strong> basal insulin requirements in individuals with diabetes.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Overall<strong> longest acting insulin is insulin degludec.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Neutral protamine Hagedorn (NPH)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: NPH insulin is an <strong>intermediate-acting insulin </strong>with a <strong>duration of action </strong>that typically ranges from <strong>16 to 24 hours</strong>. While it does provide<strong> longer coverage than short-acting insulins,</strong> it does not last as long as insulin glargine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Insulin glulisine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Insulin glulisine is a<strong> rapid-acting insulin analog </strong>with a <strong>quick onset of action</strong> (approximately <strong>15 minutes</strong>) and a <strong>shorter duration of action (3 to 5 hours)</strong>, making it <strong>well-suited for controlling blood sugar levels during meals.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lente insulin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lente insulin is an <strong>intermediate-acting insulin</strong> with a <strong>duration of action</strong> similar to <strong>NPH insulin.</strong> It is<strong> not</strong> as <strong>long-acting as insulin glargine.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INSULIN PREPARATIONS</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture15.jpg\" style=\"height:467px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 15801,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3706,
      "choices": [
        {
          "id": 14803,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">GnRH analogue</span></span></span></p>"
        },
        {
          "id": 14804,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Danazol</span></span></span></p>"
        },
        {
          "id": 14805,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyproterone acetate</span></span></span></p>"
        },
        {
          "id": 14806,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medroxyprogesterone acetate</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug of choice for treatment of central precocious puberty in girls is.</span></span></span></p>",
      "unique_key": "Q8861174",
      "question_audio": null,
      "question_video": null,
      "map_id": 36153,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. GnRH analogue</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>GnRH (Gonadotropin-Releasing Hormone) analogues</strong> are the <strong>drug of choice for the treatment of central precocious puberty,</strong> which includes<strong> early puberty onset in girls. </strong>GnRH analogues work by <strong>initially stimulating </strong>and then <strong>downregulating the pituitary gland&#39;s</strong> <strong>release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).</strong> This process leads to a <strong>decrease in sex hormone</strong> <strong>production (estrogen in girls)</strong>, effectively halting the <strong>premature progression of puberty.</strong> The use of<strong> GnRH analogues allows</strong> for the <strong>temporary suspension of sexual maturation, providing time for growth and development </strong>to resume at a more appropriate <strong>chronological age.</strong> </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Please note that<strong> </strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>GnRH agonists</strong> are <strong>not effective</strong> as therapy for<strong> peripheral precocious puberty. Androgen antagonists,</strong> <strong>spironolactone, aromatase inhibitors (Anastrozole and Letrozole), ketoconazole, and medroxy-progesterone acetate </strong>are used to<strong> </strong>treat <strong>peripheral precocious puberty.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Danazol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Danazol is a<strong> synthetic steroid </strong>with <strong>androgenic activity</strong> used to treat <strong>endometriosis and fibrocystic breast disease.</strong> It is <strong>not </strong>the <strong>drug of choice</strong> for treating<strong> precocious puberty.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Cyproterone acetate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cyproterone acetate is an <strong>anti-androgen and progestin </strong>medication used for<strong> androgen-dependent</strong> conditions like s<strong>evere acne, excessive hair growth, and androgen-sensitive prostate cancer</strong>. While it can <strong>reduce androgen effects</strong>, it is <strong>not</strong> the primary treatment for<strong> precocious puberty in girls.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Medroxyprogesterone acetate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Medroxyprogesterone acetate is a <strong>progestin</strong> used as <strong>contraception and in hormone</strong> <strong>therapy </strong>for menopausal symptoms or psychiatric conditions. It is <strong>not </strong>used as the <strong>first-line treatment for precocious puberty.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>GnRH analogues</strong> are the <strong>drug of choice</strong> for<strong> treating central precocious puberty in girls </strong>due to their ability to<strong> control and regulate the</strong> <strong>premature release of sex hormones, </strong>effectively<strong> delaying early puberty.</strong> This treatment is <strong>not</strong> applicable for <strong>peripheral precocious puberty,</strong> which requires different therapeutic approaches like <strong>androgen antagonists or aromatase inhibitors.</strong></span></span></span></p>",
      "correct_choice_id": 14803,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4241,
      "choices": [
        {
          "id": 16941,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></span></p>"
        },
        {
          "id": 16942,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride</span></span></span></p>"
        },
        {
          "id": 16943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone</span></span></span></p>"
        },
        {
          "id": 16944,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gliclazide</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs used to treat type II diabetes mellitus does not cause weight gain? </span></span></span></p>",
      "unique_key": "Q9446355",
      "question_audio": null,
      "question_video": null,
      "map_id": 36151,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Metformin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Metformin </strong>is an <strong>oral antidiabetic medication </strong>that is commonly used as the <strong>first-line treatment for type 2 diabetes mellitus</strong>. One of its benefits, in addition to <strong>lowering blood glucose levels</strong>, is that it <strong>does not cause weight gain</strong> and may even lead to <strong>slight weight</strong> <strong>loss</strong> in some patients. Metformin works by <strong>decreasing hepatic glucose production</strong> and <strong>increasing insulin sensitivity </strong>in<strong> peripheral</strong> <strong>tissues.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glimepiride:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glimepiride is a <strong>sulfonylurea</strong>, which works by <strong>increasing insulin secretion</strong> from the <strong>pancreas.</strong> Sulfonylureas can cause<strong> weight gain as a side effect.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pioglitazone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pioglitazone is a <strong>thiazolidinedione,</strong> which <strong>improves insulin sensitivity </strong>but is associated with<strong> weight gain,</strong> often due to<strong> fluid retention and fat accumulation.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Gliclazide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Gliclazide is another<strong> sulfonylurea</strong> with a mechanism of action <strong>similar to glimepiride,</strong> and it can also cause <strong>weight gain.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Effect of antidiabetic drugs on weight </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/picture2.jpg\" style=\"height:153px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 16941,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4268,
      "choices": [
        {
          "id": 17049,
          "text": "<p><span style=\"font-size:12pt;\">They are active orally.</span></p>"
        },
        {
          "id": 17050,
          "text": "<p><span style=\"font-size:12pt;\">They are estrogen antagonists in all tissues.</span></p>"
        },
        {
          "id": 17051,
          "text": "<p><span style=\"font-size:12pt;\">They have tissue-specific effects.</span></p>"
        },
        {
          "id": 17052,
          "text": "<p><span style=\"font-size:12pt;\">They are more potent than 17-β-estradiol.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A second-year medical student is studying the pharmacological properties of estrogens and Selective Estrogen Receptor Modulators (SERMs) to understand their therapeutic applications and mechanisms of action. The student is particularly interested in how SERMs are different compare to natural estrogens, such as 17-β-estradiol, in their mode of action and effects on various tissues.&nbsp;Compared to 17-β-estradiol, a natural estrogen, which of the following properties is characteristic of Selective Estrogen Receptor Modulators (SERMs)?”</span></p>",
      "unique_key": "Q5655501",
      "question_audio": null,
      "question_video": null,
      "map_id": 36149,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. They have tissue-specific effects.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Selective Estrogen Receptor Modulators (SERMs),</strong> such as <strong>tamoxifen and raloxifene</strong>, are characterized by their ability to act as <strong>both</strong> <strong>agonists and antagonists of estrogen receptors, </strong>depending on the<strong> tissue type</strong>. This is a key <strong>difference </strong>from <strong>17-β-estradiol</strong>, which typically <strong>acts as a uniform agonist </strong>across <strong>all estrogen-responsive tissues</strong>. <strong>SERMs</strong> can selectively <strong>mimic</strong> or <strong>block the effects of</strong> <strong>estrogen, </strong>making them <strong>versatilb</strong> in clinical applications, such as in the <strong>treatment of breast cancer </strong>where they <strong>exhibit antagonistic</strong> <strong>properties,</strong> and in <strong>osteoporosis prevention</strong> where they <strong>act as agonists.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. They are active orally: </strong>While many<strong> SERMs</strong> are indeed <strong>orally active,</strong> this is<strong> not </strong>a distinctive feature compared to17-β-<strong>estradiol,</strong> which can also be <strong>administered orally </strong>in its synthetic forms.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. They are estrogen antagonists in all tissues:</strong> This is <strong>not accurate. SERMs do not </strong>uniformly act as <strong>estrogen antagonists in all tissues</strong>. Instead, their action is <strong>selective like raloxifene is agonistic in some tissues</strong> (like <strong>bones and cardiovascular system</strong>) and <strong>antagonistic</strong> in others (like<strong> breast and uterine tissues</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. They are more potent than 17-β-estradiol:</strong> This is <strong>not </strong>necessarily <strong>true</strong>. The potency of<strong> SERMs compared to 17-β-estradiol</strong> varies and is<strong> not</strong> the primary <strong>distinguishing facto</strong>r. Their significance lies in their <strong>selective action</strong> <strong>rather than</strong> their<strong> overall potency.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The defining characteristic of<strong> Selective Estrogen Receptor Modulators (SERMs)</strong> is their <strong>tissue-specific effects</strong>, enabling them to <strong>selectively modulate estrogen receptors</strong> in<strong> different tissues</strong>, which <strong>contrasts</strong> with the<strong> uniform agonist activity</strong> of n<strong>atural estrogens</strong> like <strong>17-β-estradiol </strong>across all <strong>estrogen-responsive tissues.</strong></span></p>",
      "correct_choice_id": 17051,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3664,
      "choices": [
        {
          "id": 14635,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bile acid sequestrant</span></span></span></p>"
        },
        {
          "id": 14636,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">LPL activator</span></span></span></p>"
        },
        {
          "id": 14637,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CETP inhibitor</span></span></span></p>"
        },
        {
          "id": 14638,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLP-1 analogue</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exenatide is a new drug approved for treatment of type 2 diabetes mellitus. What is the mechanism of action of this drug? </span></span></span></p>",
      "unique_key": "Q9968992",
      "question_audio": null,
      "question_video": null,
      "map_id": 36150,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. GLP-1 analogue</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Exenatide </strong>functions as a<strong> GLP-1 (glucagon-like peptide-1) analogue</strong>. This class of <strong>drugs enhances the body&rsquo;s ability </strong>to <strong>regulate blood sugar </strong>by <strong>mimicking the effects </strong>of the naturally occurring <strong>hormone GLP-1</strong>.<strong> Exenatide </strong>stimulates the<strong> pancreas to release insulin more </strong>efficiently when<strong> blood glucose levels are high</strong>. It also<strong> reduces </strong>the rate at which <strong>glucose is absorbed into the bloodstream </strong>by<strong> slowing gastric emptying and suppresses the appetite</strong>, which collectively helps in managing <strong>type 2 diabetes. </strong>It is <strong>administered </strong>via the <strong>subcutaneous route</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bile acid sequestrant:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect for Exenatide. </strong>Bile acid sequestrants, such as <strong>cholestyramine and colestipol, </strong>are primarily used to manage<strong> dyslipidemia by binding bile acids </strong>in the intestine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. LPL activator:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect </strong>for Exenatide. Drugs that <strong>activate lipoprotein lipase (LPL), </strong>such as <strong>fibrates, </strong>are used to treat <strong>hypertriglyceridemia </strong>by enhancing the breakdown of<strong> triglyceride-rich lipoproteins</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. CETP inhibitor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect </strong>for Exenatide. CETP inhibitors, like <strong>anacetrapib, </strong>are used to <strong>increase high-density lipoprotein (HDL) cholesterol levels </strong>by <strong>inhibiting </strong>the <strong>cholesteryl ester transfer protein</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Exenatide</strong>, as a <strong>GLP-1 analogue</strong>, is effective in treating <strong>type 2 diabetes </strong>by enhancing <strong>insulin secretion </strong>in response to <strong>high blood glucose levels</strong>, <strong>slowing gastric emptying, and reducing appetite</strong>, thus <strong>improving glycemic control</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parenteral Anti-diabetic drugs:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture2.jpg\" style=\"height:230px; width:500px\" /></span></strong></span></span></p>",
      "correct_choice_id": 14638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4098,
      "choices": [
        {
          "id": 16371,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduction in number of lymphocytes at the site of inflammation</span></span></span>​​​​</p>"
        },
        {
          "id": 16372,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in production of cytokines.</span></span></span></p>"
        },
        {
          "id": 16373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of phospholipase enzyme</span></span></span></p>"
        },
        {
          "id": 16374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-inflammatory action of cortisol is due to? </span></span></span></p>",
      "unique_key": "Q1825869",
      "question_audio": null,
      "question_video": null,
      "map_id": 36148,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. All the above </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Inflammatory Effects of corticosteroids</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inflammation</strong> is characterized by the <strong>extravasation and infiltration of leukocytes into the affected tissue.</strong> <strong>Glucocorticoids</strong> dramatically <strong>reduce</strong> the <strong>manifestations of inflammation. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">After a<strong> single dose of a short-acting glucocorticoid</strong>, the <strong>concentration of neutrophils </strong>in the circulation <strong>increases </strong>while the <strong>lymphocytes (T and B cells), monocytes, eosinophils, and basophils decrease</strong>. The<strong> increase in neutrophils</strong> is due <strong>both to increased influx into the blood from the bone marrow </strong>and to <strong>decreased migration from the blood vessels,</strong> leading to a<strong> reduction in the number of cells </strong>at the site of inflammation. The <strong>reduction in circulating lymphocytes,</strong> <strong>monocytes, eosinophils, and basophils</strong> is primarily the result of their <strong>movement from the vascular bed to lymphoid tissue.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucocorticoids</strong> also <strong>inhibit the functions of tissue macrophages </strong>and other <strong>antigen-presenting cells.</strong> The <strong>ability of these</strong> <strong>cells </strong>to respond to<strong> antigens and mitogens is reduced.</strong> The effect on <strong>macrophages </strong>is <strong>particularly marked </strong>and limits their <strong>ability to phagocytose and kill microorganisms </strong>and to <strong>produce tumor necrosis factor &alpha;, interleukin 1,</strong> <strong>metalloproteinases, and plasminogen activator.</strong> Both<strong> macrophages and lymphocytes </strong>produce less<strong> interleukin 12 and</strong> <strong>interferon-&gamma;,</strong> important inducers of<strong> TH1 cell activity, and cellular immunity.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In addition to their effects on <strong>leukocyte function, glucocorticoids influence the inflammatory response</strong> by <strong>inhibiting</strong> <strong>phospholipase A2 </strong>and thus reduce the<strong> synthesis of arachidonic acid, </strong>the<strong> precursor of prostaglandins and leukotrienes,</strong> and of <strong>platelet-activating factor. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finally, <strong>glucocorticoids reduce </strong>expression of <strong>cyclooxygenase 2 in inflammatory cells, </strong>thus <strong>reducing</strong> the amount of <strong>enzyme</strong> available to<strong> produce prostaglandins.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>anti-inflammatory action of cortisol </strong>and <strong>other glucocorticoids</strong> is <strong>multifactorial,</strong> involving <strong>reduction in immune cell migration</strong> to <strong>inflammation sites,</strong> <strong>decreased production of cytokines, </strong>inhibition of<strong> phospholipase A2 activity</strong>, and <strong>downregulation of COX-2</strong> <strong>expression.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 16374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}